Department of Pharmaceutical Sciences and UNTHSC Preclinical Services, University of North Texas System College of Pharmacy, University of North Texas Health Science Center, Fort Worth, TX, USA.
Department of Research, Reata Pharmaceuticals, Irving, TX, USA.
BMC Microbiol. 2020 Feb 5;20(1):27. doi: 10.1186/s12866-020-1710-5.
Clostridioides difficile infections have become more frequently diagnosed and associated with greater disease severity, which has resulted in an increase burden on the healthcare system. These increases are attributed to the increased prevalence of hypervirulent strains encompassing select ribotypes. These epidemic ribotypes were characterized as hypervirulent due to higher in vitro spore and toxin production, as well as increased incidence, severity and mortality within patients. However, it is unclear whether epidemic ribotypes are truly more virulent than non-epidemic ribotypes in vivo. Furthermore, there is conflicting evidence about the ability of a strain's in vitro phenotype to be predictive of their in vivo virulence. The goals of the current studies were to determine if epidemic ribotypes are more virulent than other ribotypes in animal models, and whether the in vitro virulence phenotype of an isolate or ribotype predict in vivo virulence.
To determine if epidemic strains were truly more virulent than other non-epidemic strains, the in vivo virulence of 13 C. difficile isolates (7 non-epidemic and 6 epidemic ribotype isolates) were determined in murine and hamster models of CDI. The isolates of epidemic ribotype of C. difficile were found to be more virulent in both the murine and hamster models than non-epidemic isolates. In particular, the group of epidemic ribotypes of C. difficile had lower LD values in hamsters. The increased severity of disease was associated with higher levels of Toxin A and Toxin B production found in fecal samples, but not numbers of organisms recovered. The isolates were further characterized for their in vitro virulence phenotypes, e.g. toxin production, growth rates, spore formation and adherence of spores to intestinal epithelial cell lines. Although there were higher levels of toxins produced and greater adherence for the group of epidemic ribotypes, the in vitro profiles of individual isolates were not always predictive of their in vivo virulence.
Overall, the group of epidemic ribotypes of C. difficile were more virulent in vivo despite individual isolates having similar phenotypes to the non-epidemic isolates in vitro.
艰难梭菌感染的诊断变得更加频繁,并且与更严重的疾病严重程度相关,这导致医疗保健系统的负担增加。这些增加归因于包含特定核糖体型的高毒力菌株的患病率增加。这些流行的核糖体型由于更高的体外孢子和毒素产生以及患者中更高的发病率,严重程度和死亡率而被认为是高毒力的。然而,尚不清楚流行的核糖体型在体内是否确实比非流行的核糖体型更具毒力。此外,关于菌株体外表型预测其体内毒力的能力存在相互矛盾的证据。目前研究的目的是确定流行核糖体型在动物模型中是否比其他核糖体型更具毒力,以及分离株或核糖体型的体外毒力表型是否可预测体内毒力。
为了确定流行菌株是否确实比其他非流行菌株更具毒力,在艰难梭菌的 13 个分离株(7 个非流行和 6 个流行核糖体型分离株)的体内毒力在 CDI 的小鼠和仓鼠模型中进行了测定。发现艰难梭菌的流行核糖体型分离株在小鼠和仓鼠模型中均比非流行分离株更具毒力。特别是,艰难梭菌的流行核糖体型组在仓鼠中的 LD 值较低。疾病严重程度的增加与粪便样本中发现的毒素 A 和毒素 B 产生水平升高有关,但与回收的生物体数量无关。进一步对分离株的体外毒力表型(例如毒素产生,生长速度,孢子形成和孢子对肠上皮细胞系的粘附)进行了特征描述。尽管流行核糖体型组产生的毒素水平更高,并且粘附性更强,但个别分离株的体外表型并不总是能预测其体内毒力。
总体而言,尽管个别分离株在体外与非流行分离株具有相似的表型,但艰难梭菌的流行核糖体型组在体内更具毒力。